Advertisement
Research Article| Volume 1, ISSUE 4, P713-727, December 1981

Vitamin D Assessment: The Assays and Their Applications

DOI:https://doi.org/10.1016/S0272-2712(18)31076-X
Vitamin D Assessment: The Assays and Their Applications
Previous ArticleVitamin A
Next ArticleIron
      This paper is only available as a PDF. To read, Please Download here.
      The normal metabolism and physiology of vitamin D are discussed, and the methodology and clinical applications of assays, such as high performance liquid chromatography, to detect and measure vitamin D and its metabolites in biologic samples are evaluated.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.

      Content published before 2002 is available via pay-per-view purchase only.

      Subscribe:

      Subscribe to Clinics in Laboratory Medicine
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Register: Create an account
      Institutional Access: Sign in to ScienceDirect

      References

        • Bayard F.
        • Bee P.
        • Louvet J.P.
        Measurement of plasma 25-hydroxycholecalciferol in man.
        Eur. J. Clin. Invest. 1972; 2: 195-198
        • Belsey R.
        • DeLuca H.F.
        • Potts J.T.
        Competitive binding assay for vitamin D and 25-hydroxyvitamin D.
        J. Clin. Endocrinol. 1971; 33: 554-557
        • Belsey R.E.
        • DeLuca H.F.
        • Potts J.T.
        A rapid assay for 25-OH-vitamin D3 without preparative chromatography.
        J. Clin. Endocrinol. Metab. 1974; 33: 1051
        • Bjorkhem I.
        • Holmberg I.
        • Kristiansen T.
        • et al.
        Assay of 1,25-dihydroxyvitamin D3 by isotope dilution-mass fragmentography.
        Clin. Chem. 1979; 25: 584-588
        • Bouillon R.
        • DeMoor P.
        • Baggiolini E.G.
        • et al.
        A radioimmunoassay for 1,25-dihydroxycholecalciferol.
        Clin. Chem. 1980; 26: 562-567
        • Bouillon R.
        • van Kerkhove P.
        • DeMoor P.
        Measurement of 25-hydroxyvitamin D3 in serum.
        Clin. Chem. 1976; 22: 364-368
        • Brumbaugh P.F.
        • Haussier D.H.
        • Bressler R.
        • et al.
        Radioreceptor assay for 1,25-dihydroxyvitamin D3.
        Science. 1974; 183: 1089-1091
        • Brumbaugh P.F.
        • Haussier D.H.
        • Bursae K.M.
        • et al.
        Filter assay for 1,25-dihydroxyvitamin D3. Utilization of the hormone’s target tissue chromatin receptor.
        Biochem. 1974; 13: 4091-4097
        • Caldas A.E.
        • Gray R.W.
        • Lemann J.
        The simultaneous measurement of vitamin D metabolites in plasma: Studies in healthy adults and in patients with calcium nephrolithiasis.
        J. Lab. Clin. Med. 1978; 91: 840-849
        • Chesney R.W.
        • Rosen J.F.
        • Hamstra A.J.
        • et al.
        Absence of seasonal variations in serum concentrations of 1,25-dihydroxyvitamin D despite a rise in 25-hydroxyvitamin D in summer.
        J. Clin. Endocrinol. Metab. 1981; 53: 139-142
        • Clemens T.L.
        • Hendy G.N.
        • Graham R.F.
        • et al.
        A radioimmunoassay for 1,25-dihydroxycholecalciferol.
        Clin. Sei. Mol. Med. 1978; 54: 329-332
        • Corradino R.A.
        Diphenylhydantoin: Direct inhibition of the vitamin D3-mediated calcium absorptive mechanism in organcultured duodenum.
        Biochem. Pharm. 1976; 25: 863-864
        • Dabek J.T.
        • Harkonen M.
        • Adlercreutz H.
        A sensitive and simplified receptor assay for 1,25-(OH)2 vitamin D.
        Scancl. J. Clin. Lab. Invest. 1981; 41: 151-158
        • DeLuca H.F.
        • Blunt J.W.
        Vitamin D.
        Meth. Enzymol. 1971; 18: 709-733
        • Delvin E.E.
        • Dussault M.
        • Glorieux F.H.
        A simplified assay for serum 25-hydroxycalciferol.
        Clin. Biochem. 1980; 13: 106-108
        • Dokoh S.
        • Morita R.
        • Fukunaga M.
        • et al.
        Competitive protein binding assay for 1,25-dihydroxyvitamin D in human plasma.
        Endocrinol. Japon. 1978; 25: 431-436
        • Dorantes L.M.
        • Arnaud S.
        • Arnaud C.
        • et al.
        Importance of the isolation of 25-hydroxyvitamin D before assay.
        J. Lab. Clin. Med. 1978; 91: 791-796
        • Drezner M.K.
        • Feinglos M.N.
        Osteomalacia due to a 1,25-dihydroxycholecalciferol deficiency.
        J. Clin. Invest. 1977; 60: 1046-1053
        • Eastwood J.B.
        • deWardener H.E.
        • Gray R.W.
        • et al.
        Normal plasma l,25-(OH)2-vitamin D concentrations in nutritional osteomalacia.
        Lancet. 1979; 1: 1377-1378
        • Edelstein S.
        • Charman M.
        • Lawson D.E.M.
        • et al.
        Competitive protein-binding assay for 25-hydroxycholecalciferol.
        Clin. Sei. Mol. Med. 1974; 46: 231-240
        • Eil C.
        • Liberman U.A.
        • Rosen J.F.
        • et al.
        A cellular defect in hereditary vitamin D-dependent rickets type II: Defective nuclear uptake of 1,25-dihydroxyvitamin D in cultured skin fibroblasts.
        New Engl. J. Med. 1981; 304: 1588-1591
        • Eisman J.A.
        • Hamstra A.J.
        • Kream B.E.
        • et al.
        1,25-dihydroxyvitamin D in biological fluids: A simplified and sensitive assay.
        Science. 1976; 193: 1021-1023
        • Eisman J.A.
        • Hamstra A.J.
        • Kream B.E.
        • et al.
        A sensitive, precise, and convenient method for determination of 1,25-dihydroxyvitamin D in human plasma.
        Arch. Biochem. Biophys. 1976; 176: 235-243
        • Eisman J.A.
        • Shepard R.M.
        • DeLuca H.F.
        Determination of 25-hydroxyvitamin D2 and 25-hydroxyvitamin D3 in human plasma using high-pressure liquid chromatography.
        Anal. Biochem. 1977; 80: 298-305
        • Ellis G.
        • Dixon K.
        Sequential-saturation-type assay for serum 25-hydroxyvitamin D.
        Clin. Chem. 1977; 23: 855-862
        • Gallagher J.C.
        • Riggs B.L.
        • Eisman J.
        • et al.
        Impaired production of 1,25-dihydroxyvitamin D in postmenopausal osteoporosis.
        Clin. Res. 1976; 24: 580A
        • Garcia-Pascual B.
        • Peytremann A.
        • Courvoisier B.
        • et al.
        A simplified competitive protein-binding assay for 25-hydroxycalciferol.
        Clin. Chim. Acta. 1976; 68: 99-105
        • Gertner J.M.
        • Lilburn M.
        • Domeneck M.
        25-hydroxycholecalciferol absorption in steatorrhoea and postgastrectomy osteomalacia.
        Br. Med. J. 1977; 1: 1310-1312
        • Gilbertson T.J.
        • Stryd R.P.
        High-performance liquid chromatographic assay for 25-hydroxyvitamin D3 in serum.
        Clin. Chem. 1977; 23: 1700-1704
        • Glorieux F.H.
        • Marie P.J.
        • Pettifor J.M.
        • et al.
        Bone response to phosphate salts, ergocalciferol, and calcitriol in hypophosphatemic vitamin D-resistant rickets.
        New Engl. J. Med. 1980; 303: 1023-1031
        • Gray R.W.
        • Adams N.D.
        • Caldas A.E.
        • et al.
        The effects of dihydrotachysterol therapy on the measurement of plasma l,25-(OH)2-vitamin D in humans.
        J. Lab. Clin. Med. 1979; 93: 1031-1034
        • Gray T.K.
        • McAdoo T.
        • Pool D.
        A modified radioimmunoassay for 1,25-dihydroxycholecalciferol.
        Clin. Chem. 1981; 27: 458-463
        • Haddad J.G.
        • Chyu K.J.
        Competitive protein-binding radioassay for 25-hydroxycholecalciferol.
        J. Clin. Endocrinol. 1971; 33: 992-995
        • Haddad J.G.
        • Hahn T.J.
        Natural and synthetic sources of circulating 25-hydroxyvitamin D in man.
        Nature. 1973; 244: 515-517
        • Haddad J.G.
        • Min C.
        • Walgate J.
        • et al.
        Competition by 24, 25-dihydroxycholecalciferol in the competitive protein binding radioassay of 25-hydroxycalciferol.
        J. Clin. Endocrinol. Metab. 1976; 43: 712-715
        • Haddad J.G.
        • Stamp T.C.B.
        Circulating 25-hydroxyvitamin D in man.
        Am. J. Med. 1974; 57: 57-62
        • Hahn T.J.
        • Birge S.J.
        • Scharp C.R.
        • et al.
        Phenobarbital-induced alterations in vitamin D metabolism.
        J. Clin. Invest. 1972; 51: 741-748
        • Hahn T.J.
        • Hendin B.A.
        • Scharp C.R.
        • et al.
        Serum 25-hydroxycalciferol levels and bone mass in children on chronic anticonvulsant therapy.
        New Engl. J. Med. 1975; 292: 550-554
        • Hahn T.J.
        • Scharp C.R.
        • Richardson C.A.
        • et al.
        Interaction of diphenylhydantoin (phenytoin) and phenobarbital with hormonal mediation of fet al rat bone resorption in vitro.
        J. Clin. Invest. 1978; 62: 406-414
        • Haussier M.R.
        Radioreceptor assay for 1,25-(OH)2-D: Clinical defects in vitamin D metabolism.
        in: Norman A.W. Vitamin D: Molecular Biology and Clinical Nutrition. Marcel Dekker, New York1980: 603-634
        • Haussier M.R.
        • Baylink D.J.
        • Hughes M.R.
        • et al.
        The assay of 1,25-dihydroxyvitamin D3: Physiologic and pathologic modulation of circulating hormone levels.
        Clin. Endocrinol. 1976; 5: 151S-165S
        • Hill L.F.
        • Taylor C.M.
        • Mawer E.B.
        Bioassay of 1,25-dihydroxycholecalciferol.
        Clin. Sei. Mol. Med. 1974; 47: 14P
        • Holick M.F.
        • Kleiner-Bossaller A.
        • Schnoes H.K.
        • et al.
        1,24,25-trihydroxy vitamin D3: A metabolite of vitamin D3 effective on intestine.
        J. Biol. Chem. 1973; 248: 6691-6696
        • Hughes M.R.
        • Baylink D.J.
        • Jones P.G.
        • et al.
        Radioligand receptor assay for 25-hydroxyvitamin D2/D3 and 1,25-dihydroxyvitamin D2/D3.
        J. Clin. Invest. 1976; 58: 61-70
        • Jones G.
        Assay of vitamins D2 and D3, and 25-hydroxyvitamins D2 and D3 in human plasma by high-performance liquid chromatography.
        Clin. Chem. 1978; 24: 287-298
        • Jones G.
        • Schnoes H.G.
        • DeLuca H.F.
        An in vitro study of vitamin D2 hydroxylases in the chick.
        J. Biol. Chem. 1976; 251: 24-28
        • Jongen M.J.M.
        • van der Vijgh W.J.F.
        • Willems H.J.J.
        • et al.
        Analysis for 1,25-dihydroxyvitamin D in human plasma, after a liquid chromatographic purification procedure, with a modified competitive protein-binding assay.
        Clin. Chem. 1981; 27: 444-450
        • Jubiz W.
        • Haussier M.R.
        • McCain T.A.
        • et al.
        Plasma 1,25-dihydroxyvitamin D levels in patients receiving anticonvulsant drugs.
        J. Clin. Endocrinol. Metab. 1977; 44: 617-621
        • Justova V.
        • Starka L.
        • Wilczek H.
        • et al.
        A simple radioassay for 25-hydroxycholecalciferol without chromatography.
        Clin. Chim. Acta. 1976; 70: 97-102
        • Krawitt E.L.
        • Grundman M.J.
        • Mawer E.B.
        Absorption, hydroxy lati on, and excretion of vitamin D3 in primary biliary cirrhosis.
        Lancet. 1977; 2: 1246-1249
        • Lambert P.W.
        • Syverson B.J.
        • Arnaud C.D.
        • et al.
        Isolation and quantitation of endogenous vitamin D and its physiologically important metabolites in human plasma by high pressure liquid chromatography.
        J. Steroid Biochem. 1977; 8: 929-937
        • Lissner D.
        • Mason R.S.
        • Posen S.
        Stability of vitamin D metabolites in human blood serum and plasma.
        Clin. Chem. 1981; 27: 773-774
        • Long R.G.
        • Skinner R.K.
        • Wills M.R.
        • et al.
        Formation of vitamin D metabolites from 3H- and 14C-radiolabelled vitamin D-3 in chronic liver diseases.
        Clin. Chim. Acta. 1978; 85: 311-317
        • Lund B.
        • Lund B.
        • Sorensen O.H.
        Measurement of circulating 1,25-dihydroxyvitamin D in man. Changes in serum concentrations during treatment with la-hydroxycholecalciferol.
        Acta Endocrinol. 1979; 91: 338-350
        • Mallon J.P.
        • Hamilton J.G.
        • Nauss-Karol C.
        • et al.
        An improved competitive protein binding assay for 1,25-dihydroxy-vitamin D.
        Arch. Biochem. Biophys. 1980; 201: 277-285
        • Manolagas S.C.
        • Deftos L.J.
        Studies of the internalization of vitamin D3 metabolites by cultured osteogenic sarcoma cells and their application to a non-chromatographic cytoreceptor assay for 1,25-dihydroxyvitamin D3.
        Biochem. Biophys. Res. Comm. 1980; 95: 596-602
        • Manolagas S.C.
        • Deftos L.J.
        Cytoreceptor assay for 1,25-dihydroxyvitamin D3: A novel radiometric method based on binding of the hormone to intracellular receptors in vitro.
        Lancet. 1980; 2: 401-402
        • Mason R.S.
        • Lissner D.
        • Grunstein H.S.
        • et al.
        A simplified assay for dihydroxylated vitamin D metabolites in human serum: Application to hyper- and hypovitaminosis D.
        Clin. Chem. 1980; 26: 444-450
        • Mason R.S.
        • Posen S.
        Some problems associated with assay of 25-hydroxycalciferol in human serum.
        Clin. Chem. 1977; 23: 806-810
        • Morris J.F.
        • Peacock M.
        Assay of plasma 25-hydroxyvitamin D.
        Clin. Chem. Acta. 1976; 72: 383-391
        • Offermann G.
        • Dittmar F.
        A direct protein-binding assay for 25-hydroxycalciferol.
        Horm. Metab. Res. 1974; 6: 534
        • Papapoulos S.E.
        • Clemens T.L.
        • Fraher L.J.
        • et al.
        Metabolites of vitamin D in human vitamin-D deficiency: Effect of vitamin D3 or 1,25-dihydroxycholecalciferol.
        Lancet. 1980; 2: 612-615
        • Peacock M.
        • Taylor G.A.
        • Brown W.
        Plasma l,25-(OH)2 vitamin D measured by radioimmunoassay and cytosol radioreceptor assay in normal subjects and patients with primary hyperparathyroidism and renal failure.
        Clin. Chim. Acta. 1980; 101: 93-101
        • Pike J.W.
        • Haussier M.R.
        Characteristics and purification of the intestinal receptor for 1.25-dihydroxyvitamin D.
        Meth. Enzymol. 1980; 67: 508-522
        • Preece M.A.
        • O’Riordan J.L.H.
        • Lawson D.E.M.
        • et al.
        A competitive protein-binding assay for 25-hydiOxycholecalciferol and 25-hydroxyergocalciferol in serum.
        Clin. Chim. Acta. 1974; 54: 235-242
        • Reinhardt T.A.
        • Napoli J.L.
        • Beitz D.C.
        • et al.
        A new in vivo metabolite of vitamin D3: 1,25,26-trihydroxyvitamin D3.
        Biochem. Biophys. Res. Comm. 1981; 99: 302-307
        • Schaefer P.C.
        • Goldsmith R.S.
        Quantitation of 25-hydroxy cholecalciferol in human serum by high-pressure liquid chromatography.
        J. Lab. Clin. Med. 1978; 91: 104-108
        • Schmidt-Gayk H.
        • Grawunder C.
        • Tschope W.
        • et al.
        25-hydroxy-vitamin-D in nephrotic syndrome.
        Lancet. 1977; 2: 105-108
        • Scriver C.R.
        • Reade T.M.
        • DeLuca H.F.
        • et al.
        Serum 1,25-dihydroxyvitamin D levels in normal subjects and in patients with hereditary rickets or bone disease.
        New Engl. J. Med. 1978; 299: 976-979
        • Shepard R.M.
        • Horst R.L.
        • Hamstra A.J.
        • et al.
        Determination of vitamin D and its metabolites in plasma from normal and anephric man.
        Biochem. J. 1979; 182: 55-69
        • Shimotsuji T.
        • Seino Y.
        • Yabuuchi H.
        A competitive protein binding assay for plasma 25-hydroxyvitamin D3 in normal children.
        Tohoku J. Exp. Med. 1976; 118: 233-240
        • Skinner R.K.
        • Wills M.R.
        Semin 25-hydroxyvitamin D assay. Evaluation of chromato graphic and non-chromatographic procedures.
        Clin. Chim. Acta. 1977; 80: 543-554
        • Stern P.H.
        A monolog on analogs: In vitro effects of vitamin D metabolites and consideration of the mineralization question.
        Calcif. Tissue Int. 1981; 33: 1-4
        • Stern P.H.
        • DeOlazabal J.
        • Bell N.H.
        Evidence for abnormal regulation of circulating 1.25-dihydroxyvitamin D in patients with sarcoidosis and normal calcium metabolism.
        J. Clin. Invest. 1980; 66: 852-855
        • Stern P.H.
        • Hamstra A.J.
        • DeLuca H.F.
        • et al.
        A bioassay capable of measuring 1 picogram of 1.25-dihydroxyvitamin D3.
        J. Clin. Endocrinol. Metab. 1978; 46: 891-896
        • Stern P.H.
        • Phillips T.E.
        • Mavreas T.
        Bioassay of 1,25-dihydroxyvitamin D in human plasma purified by partition, alkaline extraction, and high-pressure chromatography.
        Anal. Biochem. 1980; 102: 22-30
        • Stewart A.F.
        • Horst R.
        • Deftos L.J.
        • et al.
        Biochemical evaluation of patients with cancer-associated hypercalcemia: Evidence for humoral and nonhumoral groups.
        New Engl. J. Med. 1980; 303: 1377-1383
        • Taylor C.M.
        • Hann J.
        • St. John J.
        • et al.
        1,25-dihydroxycholecalciferol in human serum and its relationship with other metabolites of vitamin D-3.
        Clin. Chim. Acta. 1979; 96: 1-8
        • van Baelen H.
        • Bouillon R.
        • De Moor P.
        Vitamin D-binding protein (Gc globulin) binds actin.
        J. Biol. Chem. 1980; 255: 2270-2272
        • Wecksler W.R.
        • Norman A.W.
        An hydroxyapatite batch assay for the quantitation of 1.25-dihydroxyvitamin D3-receptor complexes.
        Anal. Biochem. 1979; 92: 314-323
        • Whitehead M.
        • Lane G.
        • Young O.
        • et al.
        Interrelations of calcium-regulating hormones during normal pregnancy.
        Br. Med. J. 1981; 2: 10-12

      Article info

      Identification

      DOI: https://doi.org/10.1016/S0272-2712(18)31076-X

      Copyright

      © 1981 Elsevier Inc. Published by Elsevier Inc. All rights reserved.

      ScienceDirect

      Access this article on ScienceDirect

      The content on this site is intended for healthcare professionals.


      We use cookies to help provide and enhance our service and tailor content. To update your cookie settings, please visit the Cookie Preference Center for this site.
      Copyright © 2023 Elsevier Inc. except certain content provided by third parties.


      RELX